FAGRON BELGIUM
ActiveDirectors
Directors
3 directors, 1 in day-to-day management, no change since 2025
Act of 31-12-2025Appointment: PwC Bedrijfsrevisoren BV (statutory auditor)Permanent representative: Lien Winne
Board 3
Cornelia de Jong
Current
Director · since 16-06-2023 · 6-year term from 2023 · listed in the 2025 annual accounts, filed on 17-06-2026
PADILLA PAPACEIT Rafael
Current
Director · since 16-06-2023 · 6-year term from 2023 · listed in the 2025 annual accounts, filed on 17-06-2026
Current
Day-to-day management 1
Humalix
Current
Day-to-day manager · appointed in the act of 05-06-2019 · 6-year term from 2023 · Private limited company · permanent representative: CAVEYE Celine
Permanent representatives 1
CAVEYE Celine
Current
Permanent representative · appointed in the act of 05-06-2019 · for Humalix
Owners and capital
Shareholders
2 ownersChain of control
- Fagron NV
- INFINITY PHARMA
- FAGRON BELGIUM
Owners 2
- INFINITY PHARMAparentEquity €16.4m Loss of €231,419 in 2025 (loss of €822,517 in 2024) Checked score 86100%
- Fagron NVconsolidating parentEquity €573.3m Profit of €50.0m in 2025 (profit of €34.0m in 2024)consolidates
Capital transactions
Capital over time
- 02-01-2026 Capital increase of €3,000,000 · to €3,300,471.74 · no new shares · in cash
- 30-11-2023 Capital stated in the deed · €300,471.74 · 20,050 shares
Mandate history
20 people, 4 in office
- Board
- Day-to-day management
- Statutory auditor
- began earlier
- end not dated
| Name | Functions and periods |
|---|---|
| Cornelia de Jong |
|
| Rafael Padilla |
|
| PADILLA PAPACEIT Rafael |
|
| Humalix |
|
| Hernando Acosta |
|
| Davy De Vlieger |
|
| Peter De Sutter |
|
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises |
|
| PricewaterhouseCoopers Reviseurs d'Entreprises |
|
| Jumoo bvba |
|
| Johannes Stols |
|
| Kalman Petro |
|
| Corrielia de Jong |
|
| BOUVRY Christophe |
|
| Rony Lebotte |
|
| JAN PEETERS |
|
| Gerardus van Jeveren |
|
| BVBA ROMANI MANAGEMENT |
|
| Ronny Lebotte |
|
| Jessie Lison |
|